{"nct_id":"NCT00946257","title":"Subcutaneous Administration of Otelixizumab to T1DM Patients","status":"COMPLETED","status_verified_date":"2017-05","start_date":"2009-07-08","start_date_type":"ACTUAL","primary_completion_date":"2011-08-01","primary_completion_date_type":"ACTUAL","completion_date":"2013-06-25","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}